Nanoviricides Inc (NNVC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,074 | -4,082 | -1,307 | -2,198 | -1,281 |
| Depreciation Amortization | 1,542 | 1,013 | 497 | 1,478 | 1,021 |
| Accounts payable and accrued liabilities | 47 | 882 | 391 | -20 | -469 |
| Other Working Capital | -101 | 924 | 411 | 318 | -111 |
| Other Operating Activity | 2,139 | -1,604 | -1,646 | -5,790 | -4,118 |
| Operating Cash Flow | $-5,447 | $-2,867 | $-1,654 | $-6,212 | $-4,957 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -424 | -364 | -334 | -6,760 | -5,564 |
| Other Investing Activity | 0 | 0 | 0 | 1,000 | 1,000 |
| Investing Cash Flow | $-424 | $-364 | $-334 | $-5,760 | $-4,564 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 0 | 0 | 0 | 6,743 | 6,743 |
| Financing Cash Flow | $N/A | $N/A | $N/A | $6,743 | $6,743 |
| Beginning Cash Position | 31,468 | 31,468 | 31,468 | 36,697 | 36,697 |
| End Cash Position | 25,596 | 28,238 | 29,480 | 31,468 | 33,919 |
| Net Cash Flow | $-5,871 | $-3,230 | $-1,988 | $-5,229 | $-2,778 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,447 | -2,867 | -1,654 | -6,212 | -4,957 |
| Capital Expenditure | -424 | -364 | -334 | -6,760 | -5,564 |
| Free Cash Flow | -5,871 | -3,230 | -1,988 | -12,972 | -10,521 |